DE602007009286D1 - Isoindolderivate als ep4-rezeptoragonisten - Google Patents

Isoindolderivate als ep4-rezeptoragonisten

Info

Publication number
DE602007009286D1
DE602007009286D1 DE602007009286T DE602007009286T DE602007009286D1 DE 602007009286 D1 DE602007009286 D1 DE 602007009286D1 DE 602007009286 T DE602007009286 T DE 602007009286T DE 602007009286 T DE602007009286 T DE 602007009286T DE 602007009286 D1 DE602007009286 D1 DE 602007009286D1
Authority
DE
Germany
Prior art keywords
receptor agonists
derivatives
isoindol
isoindol derivatives
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007009286T
Other languages
English (en)
Inventor
Gerard Martin Giblin
Mark Patrick Healy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of DE602007009286D1 publication Critical patent/DE602007009286D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/62—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles
    • C07D209/66—Naphtho [c] pyrroles; Hydrogenated naphtho [c] pyrroles with oxygen atoms in positions 1 and 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE602007009286T 2006-10-17 2007-10-15 Isoindolderivate als ep4-rezeptoragonisten Active DE602007009286D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0620619.7A GB0620619D0 (en) 2006-10-17 2006-10-17 Novel compounds
PCT/EP2007/060932 WO2008046798A1 (en) 2006-10-17 2007-10-15 Isoindol derivatives as ep4 receptor agonists

Publications (1)

Publication Number Publication Date
DE602007009286D1 true DE602007009286D1 (de) 2010-10-28

Family

ID=37507899

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007009286T Active DE602007009286D1 (de) 2006-10-17 2007-10-15 Isoindolderivate als ep4-rezeptoragonisten

Country Status (8)

Country Link
US (1) US20100076048A1 (de)
EP (1) EP2081897B1 (de)
JP (1) JP2010506878A (de)
AT (1) ATE481384T1 (de)
DE (1) DE602007009286D1 (de)
ES (1) ES2352305T3 (de)
GB (1) GB0620619D0 (de)
WO (1) WO2008046798A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120190637A1 (en) 2009-10-14 2012-07-26 Gemmus Pharma, Inc. Combination therapy treatment for viral infections
MX2016001714A (es) 2013-08-09 2016-10-03 Ardelyx Inc Compuestos y metodos para inhibir el transporte de fosfato.
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300889A (en) * 1965-04-22 1967-01-31 Su Ev Inc Recoil snubber for guns
US3707797A (en) * 1970-11-18 1973-01-02 K Ruth Recoil absorber
US3714726A (en) * 1970-11-25 1973-02-06 P Braun Recoil stock
US3754344A (en) * 1972-04-28 1973-08-28 J Spiliotis Gun recoil absorber
US4439943A (en) * 1982-03-09 1984-04-03 Brakhage Rodney D Recoil reducer
US4910904A (en) * 1989-03-27 1990-03-27 Browning Recoil reducer for firearms
US5031348A (en) * 1990-10-01 1991-07-16 Carey Donald C Gun stock assembly with coordinated comb and recoil
US5173564A (en) * 1992-01-07 1992-12-22 Hammond Jr Claude R Quick detachable stock system and method
US5726377A (en) * 1996-06-19 1998-03-10 Colt's Manufacturing Company, Inc. Gas operated firearm
ES2274378T3 (es) * 1999-08-10 2007-05-16 Glaxo Group Limited Ligando del receptor ep4 y uso contra dolor neuropatico, cancer de colon,hiv y migraña.
US6481143B2 (en) * 2000-11-03 2002-11-19 Mccarthy Patrick M. Gun stock with recoil reduction device
GB0103269D0 (en) * 2001-02-09 2001-03-28 Glaxo Group Ltd Napthalene derivatives
US6651371B2 (en) * 2001-06-25 2003-11-25 Richard Mark Fitzpatrick Modular gunstock
US6688031B2 (en) * 2002-05-30 2004-02-10 Gerald Dale Steele Replacement adjustable competition buttstock
US6732466B2 (en) * 2002-08-19 2004-05-11 James K. Bentley Recoil system for the receiver of a firearm
US7398616B1 (en) * 2004-05-21 2008-07-15 Robert Weir Adjustable length heavy duty butt stock assembly for a firearm
US7124529B1 (en) * 2004-12-16 2006-10-24 Havelka Jr Alfred J Axially displaced gun stock recoil system
US7162822B1 (en) * 2005-01-03 2007-01-16 The United States Of America As Represented By The Secretary Of The Army Collapsible buttstock for firearm
US8207213B2 (en) * 2006-02-03 2012-06-26 Glaxo Group Limited Benzoisoindole derivatives for the treatment of pain
UY30121A1 (es) * 2006-02-03 2007-08-31 Glaxo Group Ltd Nuevos compuestos
US7992337B2 (en) * 2006-03-16 2011-08-09 Ochoa Adam A Method and apparatus to mount recoil dampening apparatus on rifle
GB0615111D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel compounds
GB0615105D0 (en) * 2006-07-28 2006-09-06 Glaxo Group Ltd Novel compounds
US7681351B2 (en) * 2006-11-15 2010-03-23 Enidine, Inc. Hydraulic recoil buffer assembly

Also Published As

Publication number Publication date
EP2081897B1 (de) 2010-09-15
GB0620619D0 (en) 2006-11-29
EP2081897A1 (de) 2009-07-29
WO2008046798A1 (en) 2008-04-24
US20100076048A1 (en) 2010-03-25
JP2010506878A (ja) 2010-03-04
ES2352305T3 (es) 2011-02-17
ATE481384T1 (de) 2010-10-15

Similar Documents

Publication Publication Date Title
ATE502921T1 (de) Substituierte indole
EA201170227A1 (ru) Имидазолкарбоксамиды
MY156822A (en) Indole derivatives as s1p1 receptor agonists
EA201071291A3 (ru) Nmda рецепторные антагонисты для лечения нейропсихиатрических расстройств
MX2010006206A (es) Derivados de oxindol substituidos por 5-halogeno y el uso de los mismos para el tratamiento de enfermedades dependientes de la vasopresina.
ATE469895T1 (de) Cgrp-rezeptorantagonisten
EA201270467A1 (ru) Полициклические соединения в качестве антагонистов рецепторов лизофосфатидной кислоты
EA201071288A1 (ru) Тризамещенные пиразолы в качестве модуляторов рецепторов ацетилхолина
MY160728A (en) Morpholinothiazoles as alpha 7 positive allosteric modulators
ATE459620T1 (de) Benzimidazolthiophenverbindungen als plk- modulatoren
UY30573A1 (es) N-(1-hetaril-piperidin-4-il)-(het)arilamidas como moduladores del receptor ep2
EA201100691A1 (ru) Антагонисты рецепторов лизофосфатидной кислоты
MY152062A (en) Indole derivatives as crth2 receptor antagonists
EA201190142A1 (ru) Производные пиразола, используемые в качестве антагонистов рецептора ccr4
ATE421518T1 (de) Dihydrochinazolinone als 5ht-modulatoren
DE602006018713D1 (de) Als agonisten für den nikotinischen acetylcholinrezeptor geeignete azabicycloalkanderivate
TN2012000147A1 (en) 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives
EA201101118A1 (ru) Фармацевтические композиции, включающие производные 2-оксо-1-пирролидина
ECSP10010379A (es) Derivados de oxindol sustituido y su uso para el tratamiento de enfermedades dependientes de la vasopresina
BRPI0915627A2 (pt) compostos derivados de indol, composições farmacêuticas que os contêm, e seus usos
ATE482195T1 (de) Benzoäfüisoindole als antagonisten des ep4- rezeptors
EA200900254A1 (ru) Производные 1h-индол-2-карбоновой кислоты, полезные в качестве модуляторов ppar
DE602007009286D1 (de) Isoindolderivate als ep4-rezeptoragonisten
TR201109686T2 (tr) Olmesartan'ın Farmasötik Bileşimleri.
ECSP088464A (es) Compuesto para la inhibición de la apoptosis